RxDoctor Payments Data

Neal Bhatia, MD

Clinical Cardiac Electrophysiology · Atlanta, GANPI 1780970806

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (36.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Medtronic at 36.4% of the total. Reporting peaked in 2023 at $17,780 and has fallen 64.4% since, to $6,334 in 2025.

$37,639in general payments, 2019–2025

Across 155 payments — averaging $242.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$14K
  • Abbott$13K
  • Dermavant Sciences, Inc.$5K
  • Almirall LLC$2K
  • Irhythm Technologies, Inc.$2K
  • Boston Scientific$637
  • plus $2K from 12 others

What the payments were for

  • Consulting fees$13,53236%
  • Speaking & faculty fees$6,37517%
  • Travel & lodging$8,88824%
  • Food & beverage$8,23722%
  • Education$6082%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$37,639 in reported general payments places this provider in the 70th percentile of 93 clinical cardiac electrophysiology providers in Georgia.

See all clinical cardiac electrophysiology providers in Georgia

Medicare billing

Part B allowed, 2024
$241,929
Medicare patients
1,139
Services billed
2,378

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban206$152,455
XareltoRivaroxaban22$23,143
FarxigaDapagliflozin Propanediol13$6,811
Metoprolol Succinate223$2,782
Flecainide Acetate86$2,538
Amiodarone Hcl113$2,042
SotalolSotalol Hcl67$1,446
Nadolol12$771
Diltiazem 24hr Er (Cd)Diltiazem Hcl13$320
Spironolactone58$259
Atorvastatin Calcium18$190
Pantoprazole Sodium29$152
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen36$144
Torsemide11$131
Carvedilol53$130

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →